Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Matthew Onaitis currently holds 15,872 shares of Somaxon Pharmaceuticals, Inc. (SOMX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew Onaitis has been a net seller of SOMX stock. They have purchased $0 and sold $582.1K worth of shares.
Matthew Onaitis's most recent insider trade was on Sep 18, 2017, when they sold 15,000 shares at $0.00 per share.
Matthew Onaitis serves as Executive at Somaxon Pharmaceuticals, Inc. (SOMX). They have executed 35 insider transactions totaling $582.1K over their tenure at the company.
Matthew Onaitis holds the position of Executive at Somaxon Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Matthew Onaitis has shown a selling trading pattern, with $0 in total purchases and $582.1K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Matthew Onaitis was on Feb 5, 2010, when they sold $181.8K worth of SOMX shares. This transaction involved 60,000 shares at $3.03 per share.
Matthew Onaitis currently owns 15,872 shares of Somaxon Pharmaceuticals, Inc. (SOMX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Matthew Onaitis's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Matthew Onaitis has 35 Form 4 filings on record as an insider at Somaxon Pharmaceuticals, Inc..
Set alerts for Matthew Onaitis and 40,000+ other insiders.